Occuity Ltd Secures £3.2m to Advance Non-Contact Ophthalmic Screening

Occuity Ltd, a London-based innovator in medical device technology, has successfully secured an estimated £3.2m in its latest funding round. The company specialises in the research, design, and production of advanced handheld non-contact optical instruments for healthcare screening and monitoring, aiming to revolutionise the early detection and management of chronic diseases through ophthalmic examination.

Founded on 6 September 2019, Occuity Ltd addresses a critical need in healthcare by developing devices that utilise light to precisely measure structures within the eye. This technology enables the detection and ongoing monitoring of serious chronic conditions such as diabetes, Alzheimer's disease, glaucoma, and myopia. By providing non-invasive and accessible screening tools, Occuity aims to empower healthcare professionals across various settings, including optometrists, ophthalmologists, hospitals, pharmacies, and care homes, to improve patient outcomes through earlier intervention.

The recent capital injection, with an allotment date of 8 April 2026 and a filing date of 20 April 2026, represents a significant boost for the company's ongoing development and commercialisation efforts. This £3.2m round follows a series of smaller, continuous capital raises that Occuity has undertaken since late 2024, demonstrating consistent investor confidence in its mission and technological advancements.

Occuity's funding journey has seen several tranches of investment over the past two years. In late 2024, the company secured £222.3k in September. This was followed by multiple allotments in December 2025 totalling approximately £786.8k, including rounds of £144.8k, £515k, and £127k. The momentum continued into early 2026, with further investments in January amounting to £392.8k across two allotments of £219.5k and £173.3k. February 2026 saw additional capital raises totalling approximately £575.7k, comprising allotments of £221.1k, £152k, and £202.6k. Prior to this, the company also raised £300k in May 2025. This latest £3.2m round significantly surpasses these individual previous allotments, indicating a substantial step forward in the company's growth trajectory and its ability to attract larger-scale investment.

In the broader UK funding landscape, the medical and dental instruments and supplies sector continues to attract investment, driven by the imperative for technological innovation in healthcare. Companies like Occuity Ltd, which are developing DeepTech solutions for critical health challenges, are vital to advancing diagnostic capabilities and improving patient care. This funding round underscores the ongoing interest in UK-based health tech firms that are pioneering non-invasive and accessible medical devices. The capital raised is expected to fuel Occuity's research and development, scale its production capabilities, and expand its market reach, ultimately bringing its innovative screening tools to a wider array of healthcare providers and patients.